The Immuno-Oncology Assay Market is estimated to be valued at USD 5.6 billion in 2024. The immuno-oncology assay market is predicted to rise at a CAGR of 12.4% from 2024 to 2034. The global immuno-oncology assay market is anticipated to reach USD 18.1 billion by 2034.
The immuno-oncology assay market is experiencing rapid growth, driven by the increasing prevalence of cancer globally and advancements in cancer immunotherapy. Immuno-oncology assays are critical tools for diagnosing cancer, predicting patient responses to treatment, and monitoring therapeutic efficacy by assessing the immune system's interactions with cancer cells.
Technological advancements play a significant role in the market's growth, with next-generation sequencing (NGS), flow cytometry, PCR, and immunoassays continuously improving assay sensitivity, specificity, and multiplexing capabilities. These innovations enable the identification of novel biomarkers and the development of companion diagnostics for personalized cancer treatment strategies.
| Attributes | Key Insights |
|---|---|
| Estimated Market Size in 2024 | USD 5.6 billion |
| Projected Market Value in 2034 | USD 18.1 billion |
| Value-based CAGR from 2024 to 2034 | 12.4% |
From 2019 to 2023, the immuno-oncology assay market experienced a CAGR of 15.4%. The approval of immune checkpoint inhibitors revolutionized cancer treatment, leading to a surge in immuno-oncology research and development.
The immuno-oncology assay market witnessed rapid growth, fueled by increasing investments in research and clinical trials. Technological advancements, such as next-generation sequencing and multiplexed immunoassays, improved assay sensitivity and specificity.
Regulatory approvals for companion diagnostics further accelerated market expansion.
The immuno-oncology assay market is expected to evolve further, with a focus on predictive and prognostic biomarkers, early cancer detection, and monitoring of treatment responses. Strategic collaborations, regulatory support, and reimbursement policies will continue to shape market dynamics.
The immuno-oncology assay market is poised for significant growth in the coming years, driven by ongoing advancements in cancer research, therapeutic innovation, and the increasing adoption of personalized medicine approaches in oncology.
Projections indicate that the global immuno-oncology assay market is expected to experience a CAGR of 12.4% from 2024 to 2034.
| Historical CAGR from 2019 to 2023 | 15.4% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 12.4% |
South Korea and Japan stand out as the top two revenue-generating countries, as indicated in the table provided. The government and private sector investments in cancer research and immunotherapy initiatives are significant drivers of market growth in South Korea.
Japanese pharmaceutical companies are at the forefront of developing immunotherapy drugs and companion diagnostics. Regulatory support and streamlined approval processes for diagnostic products contribute to market growth.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 12.1% |
| The United Kingdom | 13.9% |
| China | 13.3% |
| Japan | 14.1% |
| South Korea | 15.2% |
The immune-oncology assay market in the United States is expected to expand at a CAGR of 12.1% by 2034. The United States is at the forefront of cancer immunotherapy research and development, with significant investments from both public and private sectors.
The approval and adoption of novel immunotherapies, such as immune checkpoint inhibitors and CAR-T cell therapies, have propelled the demand for immuno-oncology assays to assess treatment efficacy and patient response.
The United States-based companies and research institutions are driving innovations in immuno-oncology assay technologies, including next-generation sequencing, flow cytometry, and multiplexed immunoassays. These technological advancements enhance assay sensitivity, specificity, and throughput, enabling comprehensive profiling of the tumor microenvironment and immune response.
The immune-oncology assay market in the United Kingdom is expected to expand at a CAGR of 13.9% by 2034. The United Kingdom is home to leading research institutions, universities, and biotechnology companies actively engaged in immuno-oncology research and development.
Collaborative efforts between academia, industry, and government agencies fuel innovation in assay technologies, biomarker discovery, and therapeutic development, driving market growth.
The United Kingdom is a significant hub for clinical trials evaluating immunotherapies across various cancer types. The adoption of immune checkpoint inhibitors, CAR-T cell therapies, and other immunotherapeutic agents in clinical practice is increasing, necessitating the use of immuno-oncology assays for patient selection, treatment monitoring, and outcome prediction.
China faces a significant burden of cancer, with increasing incidence rates due to factors such as aging population, lifestyle changes, and environmental pollution.
This high disease burden drives the demand for immuno-oncology assays for early detection, diagnosis, and treatment monitoring. United Kingdom. The immune-oncology assay market in China is expected to rise at a CAGR of 13.3% by 2034.
The Chinese government has prioritized cancer prevention, diagnosis, and treatment as part of its healthcare reforms. Initiatives to improve cancer care infrastructure, enhance access to innovative therapies, and promote research and development in oncology contribute to market growth.
Japan has a growing cancer burden due to factors such as the aging population, lifestyle changes, and environmental factors. The rising prevalence of cancer drives the demand for immuno-oncology assays for early detection, diagnosis, and treatment monitoring. The immune-oncology assay market in Japan is expected to expand at a CAGR of 14.1% by 2034.
Japan has a strong research and development infrastructure in oncology, with leading academic institutions, biotechnology companies, and healthcare centers engaged in cancer research.
The country's contributions to cancer immunotherapy research, including novel therapies and biomarker discovery, fuel the demand for immuno-oncology assays.
South Korea is actively involved in cancer immunotherapy research and development. The adoption of immune checkpoint inhibitors, CAR-T cell therapies, and other immunotherapeutic agents is increasing, driving the demand for immuno-oncology assays to assess treatment efficacy and patient response. The immune-oncology assay market in South Korea is expected to flourish at a CAGR of 15.2% by 2034.
South Korean companies are at the forefront of technological innovation in diagnostics and biotechnology. They are developing advanced immuno-oncology assay platforms, including next-generation sequencing, flow cytometry, and multiplexed immunoassays, to meet the evolving needs of cancer diagnosis and treatment.
The below section shows the leading segment. The reagents and antibodies segment is to rise at a CAGR of 12.2% from 2024 to 2034. Based on technology, the checkpoint inhibitors segment is anticipated to hold a dominant share through 2034. It is set to exhibit a CAGR of 11.9% from 2024 to 2034.
| Category | CAGR from 2024 to 2034 |
|---|---|
| Reagents and Antibodies | 12.2% |
| Checkpoint Inhibitors | 11.9% |
Based on type, the Reagents and Antibodies segment is anticipated to proliferate at a CAGR of 12.2% from 2024 to 2034.
Reagents and antibodies are essential components of immuno-oncology assays, playing crucial roles in detecting specific biomarkers, antigens, or immune cell markers associated with cancer and immunotherapy response.
Reagents and antibodies are highly specific and sensitive, allowing for the accurate detection and quantification of targets of interest in complex biological samples, such as blood, tissue, or tumor specimens.
Many immuno-oncology assays require multiplexing, where multiple targets are detected simultaneously in a single assay. Reagents and antibodies with multiplexing capabilities enable comprehensive profiling of the immune response and tumor microenvironment, providing valuable insights for cancer diagnosis and treatment.
Based on technology, the checkpoint inhibitors segment is anticipated to rise at a CAGR of 11.9% from 2024 to 2034.
Checkpoint inhibitors have revolutionized cancer treatment by enhancing the body's immune response against cancer cells. These therapies block inhibitory checkpoints, such as PD-1/PD-L1 and CTLA-4, allowing the immune system to recognize and attack cancer cells more effectively.
Biomarkers such as PD-L1 expression levels have been identified as predictors of response to checkpoint inhibitor therapy. Immuno-oncology assays are used to measure these biomarkers, allowing clinicians to identify patients who are most likely to respond to checkpoint inhibitors and tailor treatment accordingly.
The growing number of clinical trials investigating checkpoint inhibitors and combination therapies underscores their importance in immuno-oncology research. Immuno-oncology assays play a crucial role in these trials by assessing biomarker expression, immune cell profiling, and treatment responses.
Collaboration with academic institutions, research organizations, and biotechnology companies enables market players to access complementary expertise, technologies, and resources.
Partnerships facilitate biomarker discovery and validation, clinical validation studies, and the development of companion diagnostics. Collaborations also enhance market penetration, accelerate product development, and mitigate development risks.
| Attributes | Details |
|---|---|
| Estimated Market Size in 2024 | USD 5.6 billion |
| Projected Market Valuation in 2034 | USD 18.1 billion |
| Value-based CAGR 2024 to 2034 | 12.4% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in USD billion |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East and Africa |
| Key Market Segments Covered | Product, Technology, Indication, End-user, Application, Region |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
| Key Companies Profiled | AGILENT TECHNOLOGIES; Sartorius AG; NanoString Technologies; THERMO FISHER SCIENTIFIC; BIO-RAD LABORATORIES; F. HOFFMANN-LA ROCHE LTD.; PERKINELMER; ILLUMINA; QIAGEN N.V.; Charles River Laboratories |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by Indication, 2019 to 2034
Table 5: Global Market Value (US$ Million) Forecast by End-Users, 2019 to 2034
Table 6: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 9: North America Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 10: North America Market Value (US$ Million) Forecast by Indication, 2019 to 2034
Table 11: North America Market Value (US$ Million) Forecast by End-Users, 2019 to 2034
Table 12: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 15: Latin America Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 16: Latin America Market Value (US$ Million) Forecast by Indication, 2019 to 2034
Table 17: Latin America Market Value (US$ Million) Forecast by End-Users, 2019 to 2034
Table 18: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 20: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 21: Western Europe Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 22: Western Europe Market Value (US$ Million) Forecast by Indication, 2019 to 2034
Table 23: Western Europe Market Value (US$ Million) Forecast by End-Users, 2019 to 2034
Table 24: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 27: Eastern Europe Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 28: Eastern Europe Market Value (US$ Million) Forecast by Indication, 2019 to 2034
Table 29: Eastern Europe Market Value (US$ Million) Forecast by End-Users, 2019 to 2034
Table 30: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 32: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 34: South Asia and Pacific Market Value (US$ Million) Forecast by Indication, 2019 to 2034
Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by End-Users, 2019 to 2034
Table 36: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 38: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 39: East Asia Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 40: East Asia Market Value (US$ Million) Forecast by Indication, 2019 to 2034
Table 41: East Asia Market Value (US$ Million) Forecast by End-Users, 2019 to 2034
Table 42: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 44: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 46: Middle East and Africa Market Value (US$ Million) Forecast by Indication, 2019 to 2034
Table 47: Middle East and Africa Market Value (US$ Million) Forecast by End-Users, 2019 to 2034
Table 48: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Product, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Technology, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Indication, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by End-Users, 2024 to 2034
Figure 5: Global Market Value (US$ Million) by Application, 2024 to 2034
Figure 6: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 7: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 10: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 13: Global Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 14: Global Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 15: Global Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 16: Global Market Value (US$ Million) Analysis by Indication, 2019 to 2034
Figure 17: Global Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 18: Global Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 19: Global Market Value (US$ Million) Analysis by End-Users, 2019 to 2034
Figure 20: Global Market Value Share (%) and BPS Analysis by End-Users, 2024 to 2034
Figure 21: Global Market Y-o-Y Growth (%) Projections by End-Users, 2024 to 2034
Figure 22: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 23: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 24: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 25: Global Market Attractiveness by Product, 2024 to 2034
Figure 26: Global Market Attractiveness by Technology, 2024 to 2034
Figure 27: Global Market Attractiveness by Indication, 2024 to 2034
Figure 28: Global Market Attractiveness by End-Users, 2024 to 2034
Figure 29: Global Market Attractiveness by Application, 2024 to 2034
Figure 30: Global Market Attractiveness by Region, 2024 to 2034
Figure 31: North America Market Value (US$ Million) by Product, 2024 to 2034
Figure 32: North America Market Value (US$ Million) by Technology, 2024 to 2034
Figure 33: North America Market Value (US$ Million) by Indication, 2024 to 2034
Figure 34: North America Market Value (US$ Million) by End-Users, 2024 to 2034
Figure 35: North America Market Value (US$ Million) by Application, 2024 to 2034
Figure 36: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 37: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 40: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 41: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 42: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 43: North America Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 44: North America Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 45: North America Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 46: North America Market Value (US$ Million) Analysis by Indication, 2019 to 2034
Figure 47: North America Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 48: North America Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 49: North America Market Value (US$ Million) Analysis by End-Users, 2019 to 2034
Figure 50: North America Market Value Share (%) and BPS Analysis by End-Users, 2024 to 2034
Figure 51: North America Market Y-o-Y Growth (%) Projections by End-Users, 2024 to 2034
Figure 52: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 53: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 54: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 55: North America Market Attractiveness by Product, 2024 to 2034
Figure 56: North America Market Attractiveness by Technology, 2024 to 2034
Figure 57: North America Market Attractiveness by Indication, 2024 to 2034
Figure 58: North America Market Attractiveness by End-Users, 2024 to 2034
Figure 59: North America Market Attractiveness by Application, 2024 to 2034
Figure 60: North America Market Attractiveness by Country, 2024 to 2034
Figure 61: Latin America Market Value (US$ Million) by Product, 2024 to 2034
Figure 62: Latin America Market Value (US$ Million) by Technology, 2024 to 2034
Figure 63: Latin America Market Value (US$ Million) by Indication, 2024 to 2034
Figure 64: Latin America Market Value (US$ Million) by End-Users, 2024 to 2034
Figure 65: Latin America Market Value (US$ Million) by Application, 2024 to 2034
Figure 66: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 67: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 70: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 71: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 72: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 73: Latin America Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 74: Latin America Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 75: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 76: Latin America Market Value (US$ Million) Analysis by Indication, 2019 to 2034
Figure 77: Latin America Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 78: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 79: Latin America Market Value (US$ Million) Analysis by End-Users, 2019 to 2034
Figure 80: Latin America Market Value Share (%) and BPS Analysis by End-Users, 2024 to 2034
Figure 81: Latin America Market Y-o-Y Growth (%) Projections by End-Users, 2024 to 2034
Figure 82: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 83: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 84: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 85: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 86: Latin America Market Attractiveness by Technology, 2024 to 2034
Figure 87: Latin America Market Attractiveness by Indication, 2024 to 2034
Figure 88: Latin America Market Attractiveness by End-Users, 2024 to 2034
Figure 89: Latin America Market Attractiveness by Application, 2024 to 2034
Figure 90: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 91: Western Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 92: Western Europe Market Value (US$ Million) by Technology, 2024 to 2034
Figure 93: Western Europe Market Value (US$ Million) by Indication, 2024 to 2034
Figure 94: Western Europe Market Value (US$ Million) by End-Users, 2024 to 2034
Figure 95: Western Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 96: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 97: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 98: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 99: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 100: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 101: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 102: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 103: Western Europe Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 104: Western Europe Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 105: Western Europe Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 106: Western Europe Market Value (US$ Million) Analysis by Indication, 2019 to 2034
Figure 107: Western Europe Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 108: Western Europe Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 109: Western Europe Market Value (US$ Million) Analysis by End-Users, 2019 to 2034
Figure 110: Western Europe Market Value Share (%) and BPS Analysis by End-Users, 2024 to 2034
Figure 111: Western Europe Market Y-o-Y Growth (%) Projections by End-Users, 2024 to 2034
Figure 112: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 113: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 114: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 115: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 116: Western Europe Market Attractiveness by Technology, 2024 to 2034
Figure 117: Western Europe Market Attractiveness by Indication, 2024 to 2034
Figure 118: Western Europe Market Attractiveness by End-Users, 2024 to 2034
Figure 119: Western Europe Market Attractiveness by Application, 2024 to 2034
Figure 120: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 121: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 122: Eastern Europe Market Value (US$ Million) by Technology, 2024 to 2034
Figure 123: Eastern Europe Market Value (US$ Million) by Indication, 2024 to 2034
Figure 124: Eastern Europe Market Value (US$ Million) by End-Users, 2024 to 2034
Figure 125: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 126: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 127: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 128: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 129: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 130: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 131: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 132: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 133: Eastern Europe Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 134: Eastern Europe Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 135: Eastern Europe Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 136: Eastern Europe Market Value (US$ Million) Analysis by Indication, 2019 to 2034
Figure 137: Eastern Europe Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 138: Eastern Europe Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 139: Eastern Europe Market Value (US$ Million) Analysis by End-Users, 2019 to 2034
Figure 140: Eastern Europe Market Value Share (%) and BPS Analysis by End-Users, 2024 to 2034
Figure 141: Eastern Europe Market Y-o-Y Growth (%) Projections by End-Users, 2024 to 2034
Figure 142: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 143: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 144: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 145: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 146: Eastern Europe Market Attractiveness by Technology, 2024 to 2034
Figure 147: Eastern Europe Market Attractiveness by Indication, 2024 to 2034
Figure 148: Eastern Europe Market Attractiveness by End-Users, 2024 to 2034
Figure 149: Eastern Europe Market Attractiveness by Application, 2024 to 2034
Figure 150: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 151: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034
Figure 152: South Asia and Pacific Market Value (US$ Million) by Technology, 2024 to 2034
Figure 153: South Asia and Pacific Market Value (US$ Million) by Indication, 2024 to 2034
Figure 154: South Asia and Pacific Market Value (US$ Million) by End-Users, 2024 to 2034
Figure 155: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034
Figure 156: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 157: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 158: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 159: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 160: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 161: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 162: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 163: South Asia and Pacific Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 164: South Asia and Pacific Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 165: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 166: South Asia and Pacific Market Value (US$ Million) Analysis by Indication, 2019 to 2034
Figure 167: South Asia and Pacific Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 168: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 169: South Asia and Pacific Market Value (US$ Million) Analysis by End-Users, 2019 to 2034
Figure 170: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-Users, 2024 to 2034
Figure 171: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-Users, 2024 to 2034
Figure 172: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 173: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 174: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 175: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 176: South Asia and Pacific Market Attractiveness by Technology, 2024 to 2034
Figure 177: South Asia and Pacific Market Attractiveness by Indication, 2024 to 2034
Figure 178: South Asia and Pacific Market Attractiveness by End-Users, 2024 to 2034
Figure 179: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034
Figure 180: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 181: East Asia Market Value (US$ Million) by Product, 2024 to 2034
Figure 182: East Asia Market Value (US$ Million) by Technology, 2024 to 2034
Figure 183: East Asia Market Value (US$ Million) by Indication, 2024 to 2034
Figure 184: East Asia Market Value (US$ Million) by End-Users, 2024 to 2034
Figure 185: East Asia Market Value (US$ Million) by Application, 2024 to 2034
Figure 186: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 187: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 188: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 189: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 190: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 191: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 192: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 193: East Asia Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 194: East Asia Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 195: East Asia Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 196: East Asia Market Value (US$ Million) Analysis by Indication, 2019 to 2034
Figure 197: East Asia Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 198: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 199: East Asia Market Value (US$ Million) Analysis by End-Users, 2019 to 2034
Figure 200: East Asia Market Value Share (%) and BPS Analysis by End-Users, 2024 to 2034
Figure 201: East Asia Market Y-o-Y Growth (%) Projections by End-Users, 2024 to 2034
Figure 202: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 203: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 204: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 205: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 206: East Asia Market Attractiveness by Technology, 2024 to 2034
Figure 207: East Asia Market Attractiveness by Indication, 2024 to 2034
Figure 208: East Asia Market Attractiveness by End-Users, 2024 to 2034
Figure 209: East Asia Market Attractiveness by Application, 2024 to 2034
Figure 210: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 211: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034
Figure 212: Middle East and Africa Market Value (US$ Million) by Technology, 2024 to 2034
Figure 213: Middle East and Africa Market Value (US$ Million) by Indication, 2024 to 2034
Figure 214: Middle East and Africa Market Value (US$ Million) by End-Users, 2024 to 2034
Figure 215: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034
Figure 216: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 217: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 218: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 219: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 220: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 221: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 222: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 223: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 224: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 225: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 226: Middle East and Africa Market Value (US$ Million) Analysis by Indication, 2019 to 2034
Figure 227: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 228: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 229: Middle East and Africa Market Value (US$ Million) Analysis by End-Users, 2019 to 2034
Figure 230: Middle East and Africa Market Value Share (%) and BPS Analysis by End-Users, 2024 to 2034
Figure 231: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-Users, 2024 to 2034
Figure 232: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 233: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 234: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 235: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 236: Middle East and Africa Market Attractiveness by Technology, 2024 to 2034
Figure 237: Middle East and Africa Market Attractiveness by Indication, 2024 to 2034
Figure 238: Middle East and Africa Market Attractiveness by End-Users, 2024 to 2034
Figure 239: Middle East and Africa Market Attractiveness by Application, 2024 to 2034
Figure 240: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
As of 2024, the market for immune oncology assays is expected to be valued at USD 5.6 billion.
By 2034, the market value of immuno-oncology assays is expected to reach USD 18.1 billion.
From 2024 to 2034, the immuno-oncology assay market is expected to flourish at a CAGR of 12.4%
The reagent and antibodies segment is expected to rise at a CAGR of 12.2% from 2024 to 2034.
South Kore is likely the top-performing market, with a CAGR of 15.2%.
Explore Similar Insights
Immuno Oncology Assay Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
